Zynerba Pharmaceuticals, Inc. (0M40.L) LSE
1.31
+0.035(+2.76%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | N/A |
| Enterprise Value | N/A |
| P/E Ratio | -1.59 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.2 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.57 |
Fiscal Year
| Fiscal Year | N/A |
| Most Recent Quarter | N/A |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.63 |
| Return On Equity | -0.59 |
Income Statement
| Revenue | N/A |
| Revenue/Share | 0 |
| Gross Profit | N/A |
| EBITDA | N/A |
| Net Income | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Cash/Share | 1.19 |
| Total Debt | N/A |
| Total Debt/Equity | 0.01 |
| Current Ratio | 5.97 |
| Book Value Per Share | 1.08 |
Price History
| 52-Week Change | 104.55 |
| 52-Week High | 1.4 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 1.12 |
| Moving Average 200 Days | 0.72 |
Statistics
| Average Volume | 9,810 |
| Shares Outstanding | 37.56M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
